1. Discuss important abstracts related to radiotherapy from the 2022 SABCS.
2. Evaluate new breast cancer patients with multi-focal disease for surgery and radiation therapy
3. Explain why ribociblib + endocrine therapy as a 1L option for ER+ advanced breast cancer with visceral crisis or aggressive disease.
Zoom Info:
Join from a PC, Mac, iPad, iPhone or Android device:
Please click this URL to join. https://uwmadison.zoom.us/s/97354348755?pwd=REJMUWJYcGx2RGFSUUdtY0JFcU40QT09
Passcode: Grand
Or One tap mobile: +13017158592,,97354348755# US (Washington DC); +13092053325,,97354348755# US
Or join by phone:
Dial(for higher quality, dial a number based on your current location):
US: +1 301 715 8592 or +1 309 205 3325 or +1 312 626 6799 or +1 646 931 3860 or +1 929 205 6099 or +1 346 248 7799 or +1 386 347 5053 or +1 564 217 2000 or +1 669 444 9171 or +1 669 900 6833 or +1 719 359 4580 or +1 253 215 8782
Webinar ID: 973 5434 8755
International numbers available: https://uwmadison.zoom.us/u/alwvN5fNS
Or an H.323/SIP room system:
H.323: 162.255.37.11 (US West) or 162.255.36.11 (US East)
Webinar ID: 973 5434 8755
Passcode: 942613
Passcode: 942613
- 1.00 AAPA Category 1 CME
- 1.00 ACPE Contact Hours - Pharmacist
- 1.00 ACPE Contact Hours - Pharmacist Technician
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 University of Wisconsin–Madison Continuing Education Hours
- 1.00 Approved for AMA PRA Category 1 Credit™